Coming Soon – May 2019 Pediatric asthma pharmacotherapy has two main goals...
Coming Soon – May 2019 Pediatric asthma pharmacotherapy has two main goals: address underlying airway inflammation and promote bronchodilation. Physicians use two...
Coming Soon – March 2019 Pharmacotherapy for adult asthma has two main...
Coming Soon – March 2019 Pharmacotherapy for adult asthma has two main goals: address underlying airway inflammation and promote bronchodilation. Two types of therapy a...
Dupixent (Sanofi/Regeneron), a first-in-class biologic that inhibits IL-4/IL-...
Dupixent (Sanofi/Regeneron), a first-in-class biologic that inhibits IL-4/IL-13 signaling, was approved for the treatment of eosi......
MARKET OUTLOOK Long-acting beta2 agonist (LABA)/long-acting muscarinic...
MARKET OUTLOOK Long-acting beta2 agonist (LABA)/long-acting muscarinic antagonist (...
Idiopathic pulmonary fibrosis (IPF) is an orphan disease affecting...
Idiopathic pulmonary fibrosis (IPF) is an orphan disease affecting approximately 50,000 people in the United States. It is characterized by an i......
The expected date of biosimilar entry is based on multiple factors, including...
The expected date of biosimilar entry is based on multiple factors, including the following: Patent and exclusivity expiry dates. Commercial at......
MARKET OUTLOOK The COPD market is continuing its gradual shift away from...
MARKET OUTLOOK The COPD market is continuing its gradual shift away from LAB......
The asthma market consists of many well-established therapies, including...
The asthma market consists of many well-established therapies, including inhaled agents (e.g., GlaxoSmithKline’s Advair/Seretide, AstraZeneca’s Symbicort, Boehringer Ingelheim...
DRG Epidemiology's coverage of AR comprises epidemiological estimates of...
DRG Epidemiology's coverage of AR comprises epidemiological estimates of key patient populations acro...
DRG Epidemiology’s coverage of acute respiratory distress syndrome (ARDS)...
DRG Epidemiology’s coverage of acute respiratory distress syndrome (ARDS) comprises ep...
DRG Epidemiology's coverage of OSA comprises epidemiological estimates of...
DRG Epidemiology's coverage of OSA comprises epidemiological estimates of key patient populations ac......
MARKET OUTLOOK COPD is a progressive inflammatory respiratory tract and lung...
MARKET OUTLOOK COPD is a progressive inflammatory respiratory tract and lung disease characterized by airflow......
Market Outlook The asthma market in the EU5 is highly competitive. A large...
Market Outlook The asthma market in the EU5 is highly competitive. A large number of approved agents are available inc......
Cystic fibrosis (CF) is a genetic disease caused by any one of the more than 2...
Cystic fibrosis (CF) is a genetic disease caused by any one of the more than 2,000 mutations identified in the cystic fibrosis transmembrane conductance regul......
DRG Epidemiology’s coverage of sarcoidosis comprises epidemiological...
DRG Epidemiology’s coverage of sarcoidosis comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany...
MARKET OUTLOOK The chronic obstructive pulmonary disease (COPD) market is...
MARKET OUTLOOK The chronic obstructive pulmonary disease (COPD) market is experiencing increased competition a......
ARDS is an acute, severe lung injury that causes edema of the lung alveoli,...
ARDS is an acute, severe lung injury that causes edema of the lung alveoli, leading to breathing abnormalities and insufficient oxyge...
DRG Epidemiology's coverage of asthma comprises epidemiological estimates...
DRG Epidemiology's coverage of asthma comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of asthma for each country as well......
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of...
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of asthma for each country, as well...
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of...
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of asthma for each country, as...
